Main > ONCOLOGY (**) > Ovarian Cancer MET BRCA+ *** > Treatment > CN. B. PARP Inhibitor>>

---

CN. B. PARP Inhibitor>>'s subsections
(*) CN Approval Date: 2021. 05.07.
>2 Lines of CT
>Pt Sensitive & Pt-Resistant/Relaps
BRCA: BReast CAncer gene
Company
Generic Name: Pamiparib
PARP: Poly (ADP-Ribose) Polymerase
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2021. 05.04

CN. B. PARP Inhibitor>>'s products
This section has no products